VMP 36030811000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Neostigmine 2.5mg/1ml solution for injection ampoules
BNF code 1002010N0AAABAB
Virtual Therapeutic Moiety Neostigmine
Date identifier became valid 29 Oct 2018
Previous product identifier 330099008
Basis of preferred name BAN - British Approved Name
Date of name applicability 21 Jun 2004
Previous name Neostigmine 2.5mg/ml injection 1ml ampoules
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Neostigmine metilsulfate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.500
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Ontology Drug Form & Route
Form & Route solutioninjection.intramuscular
Ontology Drug Form & Route
Form & Route solutioninjection.subcutaneous
Dose Form
Formulation Solution for injection
Drug Route
Route Intramuscular
Drug Route
Route Subcutaneous
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Neostigmine 2.5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd)
Neostigmine 2.5mg/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd)
Neostigmine 2.5mg/1ml solution for injection ampoules (hameln pharma Ltd)
Virtual Medicinal Product Packs
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.

Feedback